Retinol-binding protein 4 & atherosclerosis: Risk factor or innocent bystander?
- 1 June 2009
- journal article
- editorial
- Published by Elsevier in Atherosclerosis
- Vol. 206 (1) , 38-39
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Adipocytokines and the Metabolic Complications of ObesityThe Journal of Clinical Endocrinology & Metabolism, 2008
- Retinol-binding protein-4 in experimental and clinical metabolic diseaseExpert Review of Molecular Diagnostics, 2008
- Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery diseaseDiabetologia, 2007
- Serum Retinol-Binding Protein Is More Highly Expressed in Visceral than in Subcutaneous Adipose Tissue and Is a Marker of Intra-abdominal Fat MassCell Metabolism, 2007
- Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese SubjectsDiabetes Care, 2007
- Retinol-Binding Protein 4 in Human ObesityDiabetes, 2006
- Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic SubjectsNew England Journal of Medicine, 2006
- Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetesNature, 2005
- Plasma Retinol-Binding Protein: Structure and Interactions with Retinol, Retinoids, and Transthyretin2004
- Weight-Reducing Effects of the Plasma Protein Encoded by the obese GeneScience, 1995